Anhui Huangshan Capsule Co., Ltd. Share Price

Equities

002817

CNE100002BV5

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
6.37 CNY +0.79% Intraday chart for Anhui Huangshan Capsule Co., Ltd. +3.92% -27.28%

Financials

Sales 2021 380M 52.43M 4.2B Sales 2022 428M 59.11M 4.73B Capitalization 2.68B 370M 29.62B
Net income 2021 56M 7.73M 619M Net income 2022 60M 8.28M 663M EV / Sales 2021 6.03 x
Net cash position 2021 284M 39.2M 3.14B Net cash position 2022 370M 51.11M 4.09B EV / Sales 2022 5.39 x
P/E ratio 2021
45.3 x
P/E ratio 2022
44.8 x
Employees 681
Yield 2021
0.66%
Yield 2022
0.67%
Free-Float 53.75%
More Fundamentals * Assessed data
Dynamic Chart
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Anhui Huangshan Capsule Co., Ltd. Announces Final Cash Dividend of A Shares for 2022, Payable on 07 June 2023 CI
Anhui Huangshan Capsule Co., Ltd. Approves 2022 Profit Distribution Plan CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Anhui Huangshan Capsule Posts 12% Rise in 2022 Profit MT
Anhui Huangshan Capsule Co., Ltd. Approves Board Elections CI
Shandong Lutai Holding Group Co., Ltd. completed the acquisition of a 29.99% stake in Anhui Huangshan Capsule Co., Ltd. from Yu Chunming. CI
Shandong Lutai Holding Group Co Ltd completed the acquisition of a 30% stake in Anhui Huangshan Capsule Co., Ltd.. CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Anhui Huangshan Capsule Discloses Change in Controlling Shareholder MT
Shandong Lutai Holding Group Co Ltd agreed to acquire a 30% stake in Anhui Huangshan Capsule Co., Ltd. for CNY 1.1 billion. CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+0.79%
1 week+3.92%
Current month-8.61%
1 month-5.35%
3 months-18.54%
6 months-22.51%
Current year-27.28%
More quotes
1 week
5.91
Extreme 5.91
6.52
1 month
5.81
Extreme 5.81
7.18
Current year
4.94
Extreme 4.94
9.05
1 year
4.94
Extreme 4.94
9.18
3 years
4.94
Extreme 4.94
13.21
5 years
4.94
Extreme 4.94
13.21
10 years
4.22
Extreme 4.2162
24.18
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 31/07/96
Director of Finance/CFO 47 07/12/22
Director/Board Member 42 31/03/07
Members of the board TitleAgeSince
Director/Board Member 61 07/12/22
Director/Board Member 50 07/12/22
Chief Executive Officer 49 31/07/96
More insiders
Date Price Change Volume
26/04/24 6.37 +0.79% 4,617,639
25/04/24 6.32 +0.96% 4,741,131
24/04/24 6.26 +1.62% 5,354,856
23/04/24 6.16 +1.65% 4,178,840
22/04/24 6.06 -1.14% 4,341,140

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Anhui Huangshan Capsule Co Ltd is a China-based company principally engaged in the manufacture and sales of hollow medical capsules. The Company's products mainly include gelatin hollow capsules and enteric gelatin hollow capsules. The Company is also engaged in the manufacture and sales of pharmaceutical equipment. The Company mainly distributes its products within domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002817 Stock